Helius Medical Technologies, Inc. to Release Second Quarter of Fiscal Year 2021 Financial Results on August 12, 2021GlobeNewsWire • 06/30/21
Helius Medical Technologies, Inc. to Participate in Noble Capital Markets' Virtual Road Show SeriesGlobeNewsWire • 06/08/21
Helius Medical Technologies, Inc. Appoints Frederick Fantazzia as Vice President of Sales & Marketing, North AmericaGlobeNewsWire • 06/02/21
Helius Medical Technologies, Inc. (HSDT) CEO Dane Andreeff on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/18/21
Helius Medical Technologies, Inc. Reports First Quarter 2021 Financial ResultsGlobeNewsWire • 05/17/21
Helius Medical Technologies, Inc. to Present at the Planet MicroCap Showcase on April 21stGlobeNewsWire • 04/15/21
Helius Medical Technologies, Inc. to Release First Quarter of Fiscal Year 2021 Financial Results on May 17, 2021GlobeNewsWire • 04/07/21
Helius Medical, Inc Receives U.S. Marketing Authorization for the PoNS™ DeviceGlobeNewsWire • 03/29/21
Helius Medical Technologies, Inc. to Present at the Investor Summit Group's Q1 Virtual Summit on March 23rdGlobeNewsWire • 03/17/21
Helius Medical Technologies, Inc. Appoints Sherrie Perkins to its Board of DirectorsGlobeNewsWire • 03/17/21
Helius Medical Technologies, Inc. (HSDT) CEO Dane Andreeff on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/11/21
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2020 Financial ResultsGlobeNewsWire • 03/10/21
Helius Medical Technologies to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 10, 2021GlobeNewsWire • 02/02/21
Helius Medical Technologies, Inc. Announces Closing of $11.0 Million Underwritten Public Offering and Full Exercise of Over-Allotment OptionGlobeNewsWire • 02/01/21
Helius Medical Technologies, Inc. Comments on the Centers for Medicare & Medicaid Services' Announcement Regarding New Medicare Coverage Pathway for Breakthrough Medical DevicesGlobeNewsWire • 01/20/21
Helius Medical Technologies, Inc. Regains Compliance with Nasdaq Listing StandardsGlobeNewsWire • 01/19/21
Helius Medical Technologies, Inc. to Present at the Noble Capital Markets 17th Annual Small & Microcap Investor ConferenceGlobeNewsWire • 01/15/21
Helius Medical Technologies, Inc. Submits Response to U.S. FDA in Pursuit of De Novo Classification and Clearance of the PoNS™ Device for the Treatment of Gait Deficit Due to Symptoms of Multiple SclerosisGlobeNewsWire • 01/11/21
Helius Medical Technologies, Inc. to Present at Four Upcoming Investor Conferences in JanuaryGlobeNewsWire • 01/04/21
Helius Medical Technologies' (HSDT) Management on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/13/20
Helius Medical Technologies, Inc. to Present at Upcoming Investor Conferences in NovemberGlobeNewsWire • 11/05/20
Helius Medical Technologies, Inc. Announces the Expansion to a Total of 27 Authorized PoNS Treatment™ Clinic Locations Across CanadaGlobeNewsWire • 11/04/20